Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Clinical Kidney Journal
|
October 6, 2017
Elderly patients with chronic kidney disease: do they really need referral to the nephrology clinic?
Mark McClure, Thomas Jorna, Laura Wilkinson, et al.
BMJ Case Reports
|
February 27, 2015
An unusual cause of abdominal distension: intraperitoneal bladder perforation secondary to intermittent self-catheterisation
Jennifer Martin, Liam Convie, David Mark, et al.
Nature Reviews. Rheumatology
|
November 4, 2018
Publisher Correction: B cell therapy in ANCA-associated vasculitis: current and emerging treatment options
Mark McClure, Seerapani Gopaluni, David Jayne, et al.
Nature Reviews. Rheumatology
|
August 16, 2018
B cell therapy in ANCA-associated vasculitis: current and emerging treatment options
Mark McClure, Seerapani Gopaluni, David Jayne, et al.
Alternative Therapies in Health and Medicine
|
January 15, 2018
Autonomic Response Testing Compared With Immunoglobulin E Allergy Panel Test Results: Preliminary Report
Autumn Frandsen, Mark McClure, Myung Kyu Chung, et al.
Clinical Kidney Journal
|
June 13, 2015
Clinical outcomes of a combined HIV and renal clinic
Mark McClure, G Jagjit Singh, Michael Rayment, et al.
Elife
|
June 30, 2016
Benefits of jasmonate-dependent defenses against vertebrate herbivores in nature
Ricardo Ar Machado, Mark McClure, Maxime R Hervé, et al.
Kidney International
|
March 1, 2016
Long-term graft outcomes and patient survival are lower posttransplant in patients with a primary renal diagnosis of glomerulonephritis
Rishi Pruthi, Mark McClure, Anna Casula, et al.
Transplantation
|
November 12, 2014
Bayesian analysis of glomerular filtration rate trajectories in kidney transplant recipients: a pilot study
Charles J Ferro, James Hodson, Jason Moore, et al.
Arthritis Research & Therapy
|
April 2, 2022
Alemtuzumab for refractory primary systemic vasculitis-a randomised controlled dose ranging clinical trial of efficacy and safety (ALEVIATE)
Seerapani Gopaluni, Rona Smith, Donna Goymer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Clinical Kidney Journal
|
October 6, 2017
Elderly patients with chronic kidney disease: do they really need referral to the nephrology clinic?
Mark McClure, Thomas Jorna, Laura Wilkinson, et al.
BMJ Case Reports
|
February 27, 2015
An unusual cause of abdominal distension: intraperitoneal bladder perforation secondary to intermittent self-catheterisation
Jennifer Martin, Liam Convie, David Mark, et al.
Nature Reviews. Rheumatology
|
November 4, 2018
Publisher Correction: B cell therapy in ANCA-associated vasculitis: current and emerging treatment options
Mark McClure, Seerapani Gopaluni, David Jayne, et al.
Nature Reviews. Rheumatology
|
August 16, 2018
B cell therapy in ANCA-associated vasculitis: current and emerging treatment options
Mark McClure, Seerapani Gopaluni, David Jayne, et al.
Alternative Therapies in Health and Medicine
|
January 15, 2018
Autonomic Response Testing Compared With Immunoglobulin E Allergy Panel Test Results: Preliminary Report
Autumn Frandsen, Mark McClure, Myung Kyu Chung, et al.
Clinical Kidney Journal
|
June 13, 2015
Clinical outcomes of a combined HIV and renal clinic
Mark McClure, G Jagjit Singh, Michael Rayment, et al.
Elife
|
June 30, 2016
Benefits of jasmonate-dependent defenses against vertebrate herbivores in nature
Ricardo Ar Machado, Mark McClure, Maxime R Hervé, et al.
Kidney International
|
March 1, 2016
Long-term graft outcomes and patient survival are lower posttransplant in patients with a primary renal diagnosis of glomerulonephritis
Rishi Pruthi, Mark McClure, Anna Casula, et al.
Transplantation
|
November 12, 2014
Bayesian analysis of glomerular filtration rate trajectories in kidney transplant recipients: a pilot study
Charles J Ferro, James Hodson, Jason Moore, et al.
Arthritis Research & Therapy
|
April 2, 2022
Alemtuzumab for refractory primary systemic vasculitis-a randomised controlled dose ranging clinical trial of efficacy and safety (ALEVIATE)
Seerapani Gopaluni, Rona Smith, Donna Goymer, et al.
Page
of 2